Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 83
Number of items: 83
  • Open Access
    van Kempen, Z. L. E., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van Dam, P. J., Volkers, A. G., Boekel, L., Toorop, A. A., Strijbis, E. M. M., Tas, S. W., Wolbink, G. J., Löwenberg, M., van Sandt, C., ten Brinke, A., Verstegen, N. J. M., Steenhuis, M., Kuijpers, T. W., van Ham, S. M., Rispens, T., ... T2B! immunity against SARS-CoV-2 study group (2022). Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate? Multiple sclerosis and related disorders, 57, Article 103416. https://doi.org/10.1016/j.msard.2021.103416
  • Open Access
    van den Dijssel, J., Hagen, R. R., de Jongh, R., Steenhuis, M., Rispens, T., Geerdes, D. M., Mok, J. Y., Kragten, A. H. M., Duurland, M. C., Verstegen, N. J. M., van Ham, S. M., van Esch, W. J. E., van Gisbergen, K. P. J. M., Hombrink, P., ten Brinke, A., & van de Sandt, C. E. (2022). Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8+ T memory cells in convalescent COVID-19 donors. Clinical & translational immunology, 11(10), Article e1423. https://doi.org/10.1002/cti2.1423
  • Open Access
    Wieske, L., Takkenberg, R. B., Tas, S. W., Bemelman, F. J., ten Brinke, A., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases. BMC Medicine, 20, Article 100. https://doi.org/10.1186/s12916-022-02310-7
  • Open Access
    Koers, J., Pollastro, S., Tol, S., Pico-Knijnenburg, I., Derksen, N. I. L., van Schouwenburg, P. A., van der Burg, M., van Ham, S. M., & Rispens, T. (2022). CD45RB Glycosylation and Ig Isotype Define Maturation of Functionally Distinct B Cell Subsets in Human Peripheral Blood. Frontiers in Immunology, 13, Article 891316. https://doi.org/10.3389/fimmu.2022.891316
  • Open Access
    Marsman, C., Verhoeven, D., Koers, J., Rispens, T., ten Brinke, A., van Ham, S. M., Kuijpers, T. W., & T2B Consortium (2022). Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells. Frontiers in Immunology, 13, Article 815449. https://doi.org/10.3389/fimmu.2022.815449
  • Open Access
    Verstegen, N. J. M., Hagen, R. R., van den Dijssel, J., Kuijper, L. H., Kreher, C., Ashhurst, T., Kummer, L. Y. L., Steenhuis, M., Duurland, M., de Jongh, R., de Jong, N., van der Schoot, C. E., Bos, A. V., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2022). Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273. eLife, 11, Article e77969. https://doi.org/10.7554/eLife.77969
  • Open Access
    van Asten, S. D. (2022). Mediators of intercellular communication in immune responses. [Thesis, externally prepared, Universiteit van Amsterdam].
  • Boekel, L., Steenhuis, M., Hooijberg, F., Besten, Y. R., van Kempen, Z. L. E., Kummer, L. Y., van Dam, K. P. J., Stalman, E. W., Vogelzang, E. H., Cristianawati, O., Keijzer, S., Vidarsson, G., Voskuyl, A. E., Wieske, L., Eftimov, F., van Vollenhoven, R., Kuijpers, T. W., van Ham, S. M., Tas, S. W., ... Wolbink, G. (2021). Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies. The Lancet. Rheumatology, 3(11), e778-e788. https://doi.org/10.1016/S2665-9913(21)00222-8
  • van Asten, S. D., Unger, P.-P., Marsman, C., Bliss, S., Jorritsma, T., Thielens, N. M., van Ham, S. M., & Spaapen, R. M. (2021). Soluble FAS Ligand Enhances Suboptimal CD40L/IL-21-Mediated Human Memory B Cell Differentiation into Antibody-Secreting Cells. The journal of immunology, 207(2), 449-458. https://doi.org/10.4049/jimmunol.2001390
  • Boekel, L., Hooijberg, F., van Kempen, Z. L. E., Vogelzang, E. H., Tas, S. W., Killestein, J., Nurmohamed, M. T., Boers, M., Kuijpers, T. W., van Ham, S. M., Eftimov, F., Wieske, L., Rispens, T., & Wolbink, G. J. (2021). Perspective of patients with autoimmune diseases on COVID-19 vaccination. The Lancet. Rheumatology, 3(4), e241-e243. https://doi.org/10.1016/S2665-9913(21)00037-0
Page 5 of 9